Benz Announces Results of Special Meeting of Shareholders
Vancouver, British Columbia--(Newsfile Corp. - June 27, 2025) - Benz Mining Corp. (TSXV: BZ) (ASX: BNZ) (Benz or the Company) is pleased to announce the results of voting at its Special Shareholder Meeting held on Friday, June 27, 2025, at 10am (AWST) in Perth, Australia (the Meeting).
All matters submitted to shareholders for approval as set out in the Company's Notice of Special Meeting of Shareholders and Information Circular dated May 27, 2025, were approved by the requisite majority of votes cast at the Meeting.
A total of 57,921,197 common shares were voted at the Meeting, representing approximately 22.92% of the total issued and outstanding common shares of the Company as of the record date of the Meeting.
As required under ASX Listing Rule 3.13.2, we advise details of resolutions and the proxies as set out at Appendix 1.
This announcement has been approved for release by the Company Secretary.
For more information please contact:
Mark Lynch-StauntonChief Executive OfficerBenz Mining Corp.E: mstaunton@benzmining.comT: +61 8 6143 6702
About Benz Mining Corp.
Benz Mining Corp. (TSXV: BZ) (ASX: BNZ) is a pure-play gold exploration company dual-listed on the TSX Venture Exchange and Australian Securities Exchange. The Company owns the Eastmain Gold Project in Quebec, and the recently acquired Glenburgh and Mt Egerton Gold Projects in Western Australia.
Benz's key point of difference lies in its team's deep geological expertise and the use of advanced geological techniques, particularly in high-metamorphic terrane exploration. The Company aims to rapidly grow its global resource base and solidify its position as a leading gold explorer across two of the world's most prolific gold regions.
The Glenburgh Gold Project features a Mineral Resource Estimate of 16.3Mt at 1.0 g/t Au (510,100 ounces of contained gold)1.
The Eastmain Gold Project in Quebec hosts a Mineral Resource Estimate of 1,005,000 ounces at 6.1g/t Au2 showcasing Benz's focus on high-grade, high-margin assets in premier mining jurisdictions.
To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/1818/257063_024171b9646ae8bb_001full.jpg
For more information, please visit: https://benzmining.com/.
Qualified Person's Statement (NI 43-101)
The disclosure of scientific or technical information in this news release is based on, and fairly represents, information compiled by Dr Marat Abzalov. Dr Abzalov, who is a Qualified Person as defined by NI 43-101, and member in good standing as a Fellow of The Australasian Institute of Mining and Metallurgy (#202718). Dr Abzalov has reviewed and approved the technical information in this news release. Dr Abzalov owns shares in Benz Mining Corp.
Historical Mineral Resource Estimates
All mineral resource estimates in respect of the Glenburgh Project in this news release are considered to be "historical estimates" as defined under NI 43-101- Standards of Disclosure for Mineral Projects (NI 43-101). These historical estimates are not considered to be current and are not being treated as such. These estimates have been prepared in accordance with the Australasian Code for Reporting of Exploration Results, Mineral Resources and Ore Reserves prepared by the Joint Ore Reserves Committee of the Australasian Institute of Mining and Metallurgy, Australian Institute of Geoscientists and Minerals Council of Australia (JORC Code) and have not been reported in accordance with NI 43-101. A qualified person (as defined in NI 43-101) (Qualified Person) has not done sufficient work to classify the historical estimates as current mineral resources. A Qualified Person would need to review and verify the scientific information and conduct an analysis and reconciliation of historical data in order to verify the historical estimates as current mineral resources.
Forward-Looking Statements
Certain statements contained in this news release may constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change because of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedarplus.ca. The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
Resolution
Resolution Result
Voting Method
Number of votes cast in Meeting
Instructions given to validly appointed proxies
For
Against
Withheld/ Abstained
For
Against
Withheld/ Abstained
Discretion
1(a). Ratification of Prior Issue of 6,589,939 Tranche 1 Placement CDI's under LR 7.1
Passed
Poll
56,213,17298.01%
22,0000.04%
1,120,3351.95%
56,213,17298.01%
22,0000.04%
1,120,3351.95%
-
1(b). Ratification of Prior Issue of 22,132,061 Tranche 1 Placement CDI's under LR 7.1A
Passed
Poll
57,303,17299.91%
22,0000.04%
30,3350.05%
57,303,17299.91%
22,0000.04%
30,3350.05%
-
2. Approval of Issue of Tranche 2 Placement CDIs to Spartan
Passed
Poll
57,868,86299.91%
22,0000.04%
30,3350.05%
57,868,86299.91%
22,0000.04%
30,3350.05%
-
Appendix 1: The following information is provided in accordance with ASX Listing Rule 3.13.2 and shows the number of proxy votes received prior to the Meeting. The Company notes no additional votes were cast directly in the Meeting.
1 Indicated: 13.5Mt at 1.0g/t Au for 430.7koz; Inferred: 2.8Mt at 0.9g/t Au for 79.4koz. See Historical Mineral Resource Estimates, below2 Indicated: 1.3Mt at 9.0g/t Au for 384koz; Inferred: 3.8Mt at 5.1g/t Au for 621koz.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/257063
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
an hour ago
- Bloomberg
Gabon, Afreximbank Sign $3.8 Billion Accord on Manganese, Gold
Gabon's government signed a $3.8 billion memorandum of understanding with the African Export-Import Bank to fund the development of manganese, gold trading, energy and rail infrastructure. The central African nation is the world's second-biggest producer of manganese, a mineral that's used to harden steel produced for construction, and one of the smallest members of OPEC+, pumping 220,000 barrels of crude per day. The agreement was signed at Afreximbank's annual general meeting in the Nigerian capital, Abuja, on Friday.
Yahoo
an hour ago
- Yahoo
Posthaste: Newcomers cite financial stress as their biggest challenge since moving to Canada
More than half of newcomers say financial stress is their biggest health and well-being challenge since moving to Canada, according to a new report by insurance provider Securian Canada. The study, which surveyed 1,589 newcomers, said financial stress is persistent regardless of how long they have been in Canada, with 53 per cent of those who have been here for two years or less indicating it is their main challenge and 54 per cent of those who have been here for three to five years saying the same. That's despite 75 per cent of newcomers being employed, with 56 per cent of them in full-time roles. Nearly three-quarters have a university education or higher and only 13 per cent are students. 'Canada's newcomer mosaic represents a diverse group, and most arrive highly educated and ready to contribute to the workforce,' Nigel Branker, chief executive of Securian Canada, said in a press release. 'However, despite this foundation, many still face challenges with financial security and social connections when they arrive in Canada that can persist over time.' Financial stress was highest among underinsured newcomers at 58 per cent compared to 48 per cent for those who were insured. Overall, 60 per cent of newcomers surveyed were underinsured and 20 per cent did not have any coverage. Insurance was also the financial activity that newcomers struggled with the most, with only 49 per cent feeling confident navigating it, and 42 per cent worrying about being misled. Their other top concerns were not knowing where to go for reliable information and finding it difficult or costly to get professional advice. But 82 per cent felt much more confident navigating day-to-day personal banking and 70 per cent felt the same way about international money transfers. More than half said they shared financial decision-making with someone else, and their top three sources for information on insurance were family and friends in Canada, a financial adviser and family and friends in their home country. Nearly two-thirds also said they prefer digital-first solutions for insurance management and 53 per cent said they would prefer to buy coverage online. 'Starting a new life in Canada comes with many exciting opportunities and challenges,' Branker said. 'Our research underscores the need for hybrid models that blend professional support with accessible digital platforms, empowering newcomers to make confident, informed decisions about their financial futures.' to get Posthaste delivered straight to your Canadians are facing a labour market that has deteriorated faster than in any other major advanced economy. Over the past two years, unemployment among 15 to 24 year-olds in Canada jumped 3.6 percentage points, the sharpest increase among the 25 largest economies in the Organization for Economic Co-operation and Development — including the U.S., U.K. and Australia. — Bloomberg Today's Data: Canada monthly real GDP for April, U.S. personal income and consumption for May and University of Michigan consumer sentiment index for June Earnings: Nintendo Co. Ltd., Softbank Corp. Mr. Philanthropy: Here's why billionaire Peter Gilgan can't stop giving away his money OSFI keeps big banks' stability buffer at 3.5% as trade war risks recede 'Godfather of AI' warns Canadian companies are adopting the technology too slowly How startup UniUni is beating Canada Post as it tries to become the country's newest unicorn NHL star hockey player John Tavares hasn't won his tax case against the Canada Revenue Agency yet, but here's why Canada gains if he succeeds. Find out more. Are you worried about having enough for retirement? Do you need to adjust your portfolio? Are you starting out or making a change and wondering how to build wealth? Are you trying to make ends meet? Drop us a line at wealth@ with your contact info and the gist of your problem and we'll find some experts to help you out while writing a Family Finance story about it (we'll keep your name out of it, of course). Want to learn more about mortgages? Mortgage strategist Robert McLister's Financial Post column can help navigate the complex sector, from the latest trends to financing opportunities you won't want to miss. Plus check his mortgage rate page for Canada's lowest national mortgage rates, updated daily. Visit the Financial Post's YouTube channel for interviews with Canada's leading experts in business, economics, housing, the energy sector and more. Today's Posthaste was written by Noella Ovid with additional reporting from Financial Post staff, The Canadian Press and Bloomberg. Have a story idea, pitch, embargoed report, or a suggestion for this newsletter? Email us at posthaste@ Canada just had its slowest ever population growth rate excluding the pandemic Posthaste: Canada's unemployment rate could reach 7.5% on still strong immigration, says economist
Yahoo
2 hours ago
- Yahoo
InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules
Vancouver, British Columbia--(Newsfile Corp. - June 27, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the issuance and sale of 1,952,363 of its common shares (or pre-funded warrants in lieu thereof) and short-term preferred investment options to purchase up to an aggregate of 1,952,363 common shares, at a purchase price of $2.561 per share (or pre-funded warrant in lieu thereof) and associated short-term preferred investment option. The short-term preferred investment option issued in the offering is exercisable immediately upon issuance at an exercise price of $2.436 per share and will expire eighteen months from the effective date of the Resale Registration Statement (as defined below). H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. The aggregate gross proceeds to the Company from the offering were approximately $5 million, before deducting placement agent fees and other offering expenses. The potential additional gross proceeds to the Company from the short-term preferred investment options, if fully-exercised on a cash basis, will be approximately $4.75 million. No assurance can be given that any of such short-term preferred investment options will be exercised. The Company intends to use the net proceeds from the offering to continue pipeline development of its pharmaceutical drug candidates, support commercial sales of rare cannabinoids through its subsidiary BayMedica LLC, and for general working capital purposes. The securities described above were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Act") and Regulation D promulgated thereunder and, along with the common shares underlying the short-term preferred investment options sold in the offering, have not been registered under the Act or applicable state securities laws. Accordingly, such securities may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. Pursuant to a registration rights agreement, the Company has agreed to file one or more registration statements with the SEC covering the resale of the unregistered securities to be issued in the offering (the "Resale Registration Statement"). The Company also amended certain existing preferred investment options to purchase up to an aggregate of 199,115 common shares that were previously issued in October 2023 and had an exercise price of $16.60 per share, for $0.125 per amended preferred investment option, such that the amended preferred investment options have a reduced exercise price of $2.436 per share. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About InMed: InMed Pharmaceuticals is a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. InMed's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications. For more information, visit Investor Contact: Colin ClancyVice President, Investor Relations and Corporate CommunicationsT: +1 604 416 0999E: ir@ Cautionary Note Regarding Forward-Looking Information: This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking information") within the meaning of applicable securities laws. Forward-looking statements are frequently, but not always, identified by words such as "expects", "anticipates", "believes", "intends", "potential", "possible", "would" and similar expressions. Such statements, based as they are on current expectations of management, inherently involve numerous risks, uncertainties and assumptions, known and unknown, many of which are beyond our control. Forward-looking information is based on management's current expectations and beliefs and is subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Without limiting the foregoing, forward-looking information in this news release includes, but is not limited to, statements about: the use of the net proceeds of the offering; the filing of a registration statement by InMed with the SEC covering the resale of the unregistered securities issued in the offering and the exercise of the short-term preferred investment options prior to their expiration. Additionally, there are known and unknown risk factors which could cause InMed's actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. A complete discussion of the risks and uncertainties facing InMed's stand-alone business is disclosed in InMed's Annual Report on Form 10-K, in Item 1A. of the Quarterly Report for the period ended March 31, 2025, and other filings with the Securities and Exchange Commission on All forward-looking information herein is qualified in its entirety by this cautionary statement, and InMed disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
